Takaaki Furukawa

Tokyo, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 67 publications

Association of subcutaneous adiposity with survival outcomes in advanced biliary tract cancer treated with gemcitabine, cisplatin, and immune checkpoint inhibitor.

Association of subcutaneous adiposity with survival outcomes in advanced biliary tract cancer treated with gemcitabine, cisplatin, and immune checkpoint inhibitor.

Journal: Journal of gastroenterology
Published: February 26, 2026

Patient-derived orthotopic xenograft models recapitulate the peritoneal dissemination of pancreatic cancer and delineate its transcriptional and regulatory programs.

Patient-derived orthotopic xenograft models recapitulate the peritoneal dissemination of pancreatic cancer and delineate its transcriptional and regulatory programs.

Journal: Journal of experimental & clinical cancer research : CR
Published: October 18, 2025

Relative Dose Intensity and Outcomes in Elderly Patients With Resectable Pancreatic Cancer Receiving Neoadjuvant Chemotherapy.

Relative Dose Intensity and Outcomes in Elderly Patients With Resectable Pancreatic Cancer Receiving Neoadjuvant Chemotherapy.

Journal: Journal of hepato-biliary-pancreatic sciences
Published: September 27, 2025

Gastrointestinal Bleeding after Particle Radiotherapy for Pancreatic Cancer.

Gastrointestinal Bleeding after Particle Radiotherapy for Pancreatic Cancer.

Journal: Digestion
Published: September 08, 2025

Efficacy and safety of peptide radionuclide therapy with 177Lu-DOTATATE in Japanese patients with advanced neuroendocrine neoplasm: a multicenter retrospective study (JON2203-N).

Efficacy and safety of peptide radionuclide therapy with 177Lu-DOTATATE in Japanese patients with advanced neuroendocrine neoplasm: a multicenter retrospective study (JON2203-N).

Journal: Journal of gastroenterology
Published: September 02, 2025

Changing treatment outcomes in metastatic and recurrent pancreatic cancer: a real-world comparison before and after the availability of nanoliposomal irinotecan.

Changing treatment outcomes in metastatic and recurrent pancreatic cancer: a real-world comparison before and after the availability of nanoliposomal irinotecan.

Journal: Japanese journal of clinical oncology
Published: August 27, 2025

Multicenter Retrospective Study of Efficacy of Systemic Therapy in Patients with Neuroendocrine Tumor Grade 3 (JOSC-2001).

Multicenter Retrospective Study of Efficacy of Systemic Therapy in Patients with Neuroendocrine Tumor Grade 3 (JOSC-2001).

Journal: Neuroendocrinology
Published: July 24, 2025

Adverse Events of Single Balloon Enteroscopy-assisted Endoscopic Retrograde Cholangiopancreatography in the Elderly: A Propensity Score Matching Analysis.

Adverse Events of Single Balloon Enteroscopy-assisted Endoscopic Retrograde Cholangiopancreatography in the Elderly: A Propensity Score Matching Analysis.

Journal: DEN open
Published: June 23, 2025

Clinical predictors of KRAS mutation detection in liquid biopsies for pancreatic ductal adenocarcinoma.

Clinical predictors of KRAS mutation detection in liquid biopsies for pancreatic ductal adenocarcinoma.

Journal: Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]
Published: April 19, 2025

Bone loss, osteoporosis, and fractures in patients with resected pancreatic head cancer.

Bone loss, osteoporosis, and fractures in patients with resected pancreatic head cancer.

Journal: Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]
Published: March 21, 2025

Endoscopic Retrograde Cholangiopancreatography-guided Biliary Drainage with Duckbill-type Anti-reflux Metal Stent versus Endoscopic Ultrasound-guided Hepaticogastrostomy for Malignant Distal Biliary Obstruction in Pancreatic Cancer with Duodenal Invasion.

Endoscopic Retrograde Cholangiopancreatography-guided Biliary Drainage with Duckbill-type Anti-reflux Metal Stent versus Endoscopic Ultrasound-guided Hepaticogastrostomy for Malignant Distal Biliary Obstruction in Pancreatic Cancer with Duodenal Invasion.

Journal: DEN open
Published: March 18, 2025

Phase 1/2 study of liposomal irinotecan plus S-1 for metastatic pancreatic cancer refractory to gemcitabine-based treatment.

Phase 1/2 study of liposomal irinotecan plus S-1 for metastatic pancreatic cancer refractory to gemcitabine-based treatment.

Journal: European journal of cancer (Oxford, England : 1990)
Published: February 05, 2025
Showing 1-12 of 67

Last Updated: 09/26/2026